Hiroyuki Taniguchi
- Noninvasive positive pressure ventilation in elderly patients with acute respiratory failure due to severe pneumoniaBy Yutaka Yokoyama, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka and Ryuichi HasegawaYutaka Yokoyama1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanRyuichi Hasegawa1Dept. of Respirology Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
- Risk factors of acute exacerbation of idiopathic pulmonary fibrosis-extended analysis of the pirfenidone trial in JapanBy Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, Arata Azuma, Takashi Ogura, Moritaka Suga, Yoshio Taguchi, Hiroki Takahashi, Koichiro Nakata, Atuhiko Sato, Yukihiko Sugiyama, Shoji Kudoh and Toshihiro NukiwaHiroyuki Taniguchi1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanMasahito Ebina2Dept. of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, JapanArata Azuma3Dept. of Internal Medicine, Nippon Medical School, Tokyo, JapanTakashi Ogura4Dept. of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanMoritaka Suga5Dept. of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, JapanYoshio Taguchi6Dept. of Respiratory Medicine, Tenri Hospital, Tenri, JapanHiroki Takahashi7Third Dept. of Internal Medicine, Sapporo Medical University of Medicine, Sapporo, JapanKoichiro Nakata8Dept. of Respiratory Medicine, Nakata Clinic, Tokyo, JapanAtuhiko Sato9Dept. of Respiratory Medicine, Medicine Kyoto Preventive, Kyoto, JapanYukihiko Sugiyama10Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, JapanShoji Kudoh3Dept. of Internal Medicine, Nippon Medical School, Tokyo, JapanToshihiro Nukiwa2Dept. of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
- Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPFBy Arata Azuma, Shinji Abe, Takashi Ogura, Hiroshi Mukae, Hiroyuki Taniguchi, Masashi Bando and Yukihiko SugiyamaArata Azuma1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanShinji Abe1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura2Respiratory Medicine, Kanagawa Cardiovascuiar and Respiratory Center, Yokohama, Kanagawa, JapanHiroshi Mukae3Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, JapanHiroyuki Taniguchi4Division of Respiratory Medicine, Allergic Internal Medicine, Tosei General Hospital, Seto, Aichi, JapanMasashi Bando5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanYukihiko Sugiyama5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
- Proposal for revised clasification of disease severity of idiopathic pulmonary fibrosis in JapanBy Hiroyuki Taniguchi, Kensuke Kataoka, Yasuhiro Kondoh, Sakae Homma, Michiaki Mishima, Yoshikazu Inoue, Takashi Ogura, Masashi Bando, Koichi Hagiwara, Hiroki Takahashi, Kingo Chida, Kazuma Kishi and Yukihiko SugiyamaHiroyuki Taniguchi1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanSakae Homma2Dept. of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, JapanMichiaki Mishima3Dept. of Respiratory Medicine, Kyoto University Hospital, Kyoto, JapanYoshikazu Inoue4Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanTakashi Ogura5Dept. of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanMasashi Bando6Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, JapanKoichi Hagiwara7Dept. of Respiratory Medicine, Saitama Medical University, Saitama, JapanHiroki Takahashi83rd Dept. of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, JapanKingo Chida92nd Dept. of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanKazuma Kishi10Dept. of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept. of Medicine, Jichi Medical University, Tochigi, Japan
- Recombinant thrombomodulin improves survival in acute exacerbation of idiopathic pulmonary fibrosisBy Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura and Kensuke KataokaHiroyuki Taniguchi1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept. of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
- 6-minute walk test predicts pulmonary artery pressure in patients with collagen vascular disease associated interstitial pneumoniaBy Kota Takahashi, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura and Kensuke KataokaKota Takahashi1Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, Japan
- Tolerability and efficacy of budesonide/formoterol via Turbuhaler® vs standard treatment in Japanese patients with moderate to severe COPD: 52-week phase III study resultsBy Masakazu Ichinose, Hiroyuki Nakamura, Noriharu Shijubo, Takefumi Saito, Hiroyuki Taniguchi, Toru Tsuda, Kosho Yoshikawa and Lars-Goran CarlssonMasakazu Ichinose1Third Department of Internal Medicine, Wakayama Medical University, Wakayama, JapanHiroyuki Nakamura2Department of Medicine, Sakaide City Hospital, Kagawa, JapanNoriharu Shijubo3Department of Medicine, JR Sapporo Hospital, Hokkaido, JapanTakefumi Saito4Department of Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital, Ibaraki, JapanHiroyuki Taniguchi5Department of Medicine, Tosei General Hospital, Aichi, JapanToru Tsuda6Department of Medicine, Kirigaota Tsuda Hospital, Fukuoka, JapanKosho Yoshikawa7Department of Medicine, Daido Hospital, Aichi, JapanLars-Goran Carlsson8Clinical Sciences, AstraZeneca R&D, Molndal, Sweden
- Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosisBy Shinichi Arizono, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Jun Hirasawa and Kazuyuki TabiraShinichi Arizono1Department of Rehabilitation, Tosei General Hospital, Seto, Japan3Division of Health Science, Graduate School of Health Science, Kio University, Kita-katsurahi-gun, Nara, JapanHiroyuki Taniguchi2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanYasuhiro Kondoh2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoki Kimura2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanKensuke Kataoka2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoya Ogawa1Department of Rehabilitation, Tosei General Hospital, Seto, JapanFumiko Watanabe1Department of Rehabilitation, Tosei General Hospital, Seto, JapanJun Hirasawa1Department of Rehabilitation, Tosei General Hospital, Seto, JapanKazuyuki Tabira3Division of Health Science, Graduate School of Health Science, Kio University, Kita-katsurahi-gun, Nara, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosisBy Seishu Hashimoto, Yoshio Taguchi, Takashi Hajiro, Ikkoh Yasuda, Yoshiki Ishii, Masahito Ebina, Kazuma Kishi, Hiroyuki Taniguchi, Takafumi Suda, Sakae Homma and Yukihiko SugiyamaSeishu Hashimoto1Department of Respiratory Medicine, Tenri Hospital, Tenri, Nara, JapanYoshio Taguchi1Department of Respiratory Medicine, Tenri Hospital, Tenri, Nara, JapanTakashi Hajiro1Department of Respiratory Medicine, Tenri Hospital, Tenri, Nara, JapanIkkoh Yasuda1Department of Respiratory Medicine, Tenri Hospital, Tenri, Nara, JapanYoshiki Ishii2Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, Shimotsuga-gun, Tochigi, JapanMasahito Ebina3Department of Respiratory Medicine, Tohoku Pharmaceutical University Hospital, Sendai, Miyagi, JapanKazuma Kishi4Department of Respiratory Medicine, Respiratory Center, Toranomon Hospital, Minato, Tokyo, JapanHiroyuki Taniguchi5Department of Respiratory and Allergy, Tosei General Hospital, Seto, Aichi, JapanTakafumi Suda6Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, JapanSakae Homma7Department of Respiratory Medicine, Toho University Omori Medical Center, Ota, Tokyo, JapanYukihiko Sugiyama8Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
- Quadriceps muscle oxygenation parameters during exercise in ILD patientsBy Shinichi Arizono, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Jun Hirasawa, Takuro Furukawa and Kazuyuki TabiraShinichi Arizono1Graduate School of Health Sciences, Seirei Christopher University, Hamamatsu, Shizuoka, Japan2Department of Rehabilitation, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanYasuhiro Kondoh3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoki Kimura3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanKensuke Kataoka3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoya Ogawa2Department of Rehabilitation, Tosei General Hospital, Seto, Aichi, JapanFumiko Watanabe2Department of Rehabilitation, Tosei General Hospital, Seto, Aichi, JapanJun Hirasawa2Department of Rehabilitation, Tosei General Hospital, Seto, Aichi, JapanTakuro Furukawa2Department of Rehabilitation, Tosei General Hospital, Seto, Aichi, JapanKazuyuki Tabira4Division of Health Science, Graduate school of Health Science, Kio University, Kita-katsurahi-gun, Nara, Japan
- Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidoneBy Hiroyuki Taniguchi, Arata Azuma, Takashi Ogura, Yoshikazu Inoue, Kingo Chida, Masashi Bando, Shinichi Kakutani, Shuichiro Inagaki, Moritaka Suga, Yukihiko Sugiyama, Shoji Kudoh and Toshihiro NukiwaHiroyuki Taniguchi1Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanArata Azuma2Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura3Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa, JapanYoshikazu Inoue4Department of Diffuse Lung Diseases and Respiratory Failure, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Osaka, JapanKingo Chida5Department of Respiratory Medicine, Hamamatsu Toyooka Hospital, Hamamatsu, Shizuoka, JapanMasashi Bando6Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanShinichi Kakutani7Center for Statistics and Analysis, Shionogi & Co., Ltd, Osaka, JapanShuichiro Inagaki7Center for Statistics and Analysis, Shionogi & Co., Ltd, Osaka, JapanMoritaka Suga8Center for Preventive Medicine, Saiseikai Kumamoto Hospital, Kumamoto, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanShoji Kudoh9Department of Respiratory Medicine, Fukujuji Hospital, Kiyose, Tokyo, JapanToshihiro Nukiwa10Department of Respiratory Medicine, South Miyagi Medical Center, Shibata, Miyagi, Japan
- Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosisBy Kensuke Kataoka, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Toshiaki Matsuda, Toshiki Yokoyama, Yasuhiko Yamano, Yoshio Nakahara and Mitsuaki YagiKensuke Kataoka1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiaki Matsuda1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiki Yokoyama1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiko Yamano1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYoshio Nakahara1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanMitsuaki Yagi1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
- Reduction in disease progression with nintedanib in the INPULSISâ„¢ trialsBy Vincent Cottin, Hiroyuki Taniguchi, Harold R. Collard, Luca Richeldi, Susanne Stowasser, Inga Tschoepe, Rozsa Schlenker-Herceg and Ganesh RaghuVincent Cottin1Louis Pradel Hospital, University of Lyon, Lyon, FranceHiroyuki Taniguchi2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanHarold R. Collard3Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA,Luca Richeldi4Faculty of Medicine, University of Southampton, Southampton, United KingdomSusanne Stowasser5Medical Affairs, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, GermanyInga Tschoepe6Statistics, Boehringer Ingelheim France S.A.S., Reims, FranceRozsa Schlenker-Herceg7Clinical Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT,Ganesh Raghu8Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA,
- CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPDBy Yoshio Nakahara, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda and Toshiki YokoyamaYoshio Nakahara1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiaki Matsuda1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiki Yokoyama1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
- Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosisBy Takuya Mishima, Tomoya Ogawa, Fumiko Watanabe, Jun Hirasawa, Furukawa Takurou, Yuko Tanaka, Kazuya Shingai, Yusuke Nagae, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama and Shinichi ArizonoTakuya Mishima1Department of Rehabilitation, Tosei General Hospital, Seto, JapanTomoya Ogawa1Department of Rehabilitation, Tosei General Hospital, Seto, JapanFumiko Watanabe1Department of Rehabilitation, Tosei General Hospital, Seto, JapanJun Hirasawa1Department of Rehabilitation, Tosei General Hospital, Seto, JapanFurukawa Takurou1Department of Rehabilitation, Tosei General Hospital, Seto, JapanYuko Tanaka1Department of Rehabilitation, Tosei General Hospital, Seto, JapanKazuya Shingai1Department of Rehabilitation, Tosei General Hospital, Seto, JapanYusuke Nagae1Department of Rehabilitation, Tosei General Hospital, Seto, JapanHiroyuki Taniguchi2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanYasuhiro Kondoh2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoki Kimura2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanKensuke Kataoka2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanToshiaki Matsuda2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanToshiki Yokoyama2Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanShinichi Arizono3Graduate School of Health Sciences, Seirei Christopher University, Hamamatsu, Japan
- Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung diseaseBy Jun Fukihara, Yasuhiro Kondoh, Hiroyuki Taniguchi, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama, Kenzo Ono, Yukio Kashima and Junya FukuokaArticle | Published in 2015 in European Respiratory JournalJun Fukihara1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiaki Matsuda1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiki Yokoyama1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKenzo Ono2Dept of Pathology, Tosei General Hospital, Seto, Aichi, JapanYukio Kashima3Dept of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanJunya Fukuoka3Dept of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung diseaseBy Jun Fukihara, Yasuhiro Kondoh, Hiroyuki Taniguchi, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama, Kenzo Ono, Yukio Kashima and Junya FukuokaJun Fukihara1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanYasuhiro Kondoh1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanHiroyuki Taniguchi1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanTomoki Kimura1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKensuke Kataoka1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiaki Matsuda1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanToshiki Yokoyama1Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, JapanKenzo Ono2Dept of Pathology, Tosei General Hospital, Seto, Aichi, JapanYukio Kashima3Dept of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanJunya Fukuoka3Dept of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Scoring system predicting for elevation of MPAP in IPFBy Taiki Furukawa, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama and Mitsuaki YagiTaiki FurukawaRespirogy and Allergy, Tosei General Hospital, Seto, JapanHiroyuki TaniguchiRespirogy and Allergy, Tosei General Hospital, Seto, JapanYasuhiro KondohRespirogy and Allergy, Tosei General Hospital, Seto, JapanTomoki KimuraRespirogy and Allergy, Tosei General Hospital, Seto, JapanKensuke KataokaRespirogy and Allergy, Tosei General Hospital, Seto, JapanToshiaki MatsudaRespirogy and Allergy, Tosei General Hospital, Seto, JapanToshiki YokoyamaRespirogy and Allergy, Tosei General Hospital, Seto, JapanMitsuaki YagiRespirogy and Allergy, Tosei General Hospital, Seto, Japan
- Health status predicted mortality in hypercapnic patients with noninvasive ventilationBy Toru Oga, Hiroyuki Taniguchi, Hideo Kita, Tomomasa Tsuboi, Keisuke Tomii, Morihide Ando, Eiji Kojima, Hiromi Tomioka, Yoshio Taguchi, Yusuke Kaji, Ryoji Maekura, Toru Hiraga, Naoki Sakai, Tomoki Kimura, Michiaki Mishima and Kazuo ChinToru Oga1Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, JapanHiroyuki Taniguchi2Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanHideo Kita3Respiratory Medicine, Takatsuki Red Cross Hospital, Osaka, JapanTomomasa Tsuboi4Respiratory Medicine, National Hospital Organization Minami-Kyoto Hospital, Kyoto, JapanKeisuke Tomii5Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo, JapanMorihide Ando6Pulmonary Medicine, Ogaki Municipal Hospital, Gifu, JapanEiji Kojima7Respiratory Medicine, Komaki City Hospital, Aichi, JapanHiromi Tomioka8Respiratory Medicine, Kobe City Medical Center West Hospital, Hyogo, JapanYoshio Taguchi9Respiratory Medicine, Tenri Hospital, Nara, JapanYusuke Kaji9Respiratory Medicine, Tenri Hospital, Nara, JapanRyoji Maekura10Respiratory Medicine, National Hospital Organization Toneyama Hospital, Osaka, JapanToru Hiraga10Respiratory Medicine, National Hospital Organization Toneyama Hospital, Osaka, JapanNaoki Sakai11Respiratory Medicine, Otsu Red Cross Hospital, Shiga, JapanTomoki Kimura2Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanMichiaki Mishima12Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, JapanKazuo Chin1Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
- PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosisBy Atsushi Suzuki, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Toshiaki Matsuda, Toshiki Yokoyama and Masahiko AndoAtsushi Suzuki1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanHiroyuki Taniguchi1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanYasuhiro Kondoh1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanTomoki Kimura1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanKensuke Kataoka1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanToshiaki Matsuda1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanToshiki Yokoyama1Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi JapanMasahiko Ando2Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Aichi Japan
- Benefits of supplemental oxygen on exercise capacity in IPF patients with exercise-induced hypoxemiaBy Shinichi Arizono, Hiroyuki Taniguchi, Koji Sakamoto, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Tomoya Ogawa, Fumiko Watanabe, Jun Hirasawa and Ryo KozuShinichi Arizono1School of Health Sciences, Seirei Christopher University, Hamamatsu, Japan2Department of Rehabilitation, Tosei General Hospital, Seto, JapanHiroyuki Taniguchi3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanKoji Sakamoto4Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanYasuhiro Kondoh3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoki Kimura3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanKensuke Kataoka3Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, JapanTomoya Ogawa2Department of Rehabilitation, Tosei General Hospital, Seto, JapanFumiko Watanabe2Department of Rehabilitation, Tosei General Hospital, Seto, JapanJun Hirasawa2Department of Rehabilitation, Tosei General Hospital, Seto, JapanRyo Kozu5Department of Rehabilitation Medicine, Nagasaki University Hospital, Nagasaki, Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.